Home/Filings/4/0001510964-21-000006
4//SEC Filing

Dowling Joseph D 4

Accession 0001510964-21-000006

CIK 0001510964other

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 5:01 PM ET

Size

5.8 KB

Accession

0001510964-21-000006

Insider Transaction Report

Form 4
Period: 2021-03-09
Dowling Joseph D
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-03-09+1,500,0001,500,000 total
    Exercise: $0.59Exp: 2031-03-08Common Stock (1,500,000 underlying)
Footnotes (1)
  • [F1]The option is durational-based. No option shares are vested on the date of grant. Twenty-five percent (25%) of the option shares vest and become exercisable on each of the following dates: September 1, 2021, March 1, 2022, September 1, 2022, and March 1, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

Issuer

CV Sciences, Inc.

CIK 0001510964

Entity typeother

Related Parties

1
  • filerCIK 0001611860

Filing Metadata

Form type
4
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 5:01 PM ET
Size
5.8 KB